Local acriflavine: a new therapy for rhinoscleroma.
Fifty patients with rhinoscleroma have been studied clinically, histopathologically and bacteriologically before, during and after the local application of acriflavin solution, in different concentrations, over an eight-week period. The results have been encouraging. Local acriflavine solution, in a concentration of 2 per cent, has been shown to be an effective and safe remedy for rhinoscleroma.
D000166:Acridines / Q000627:therapeutic use*; D000167:Acriflavine / Q000627:therapeutic use*; D006801:Humans; D009666:Nose / Q000473:pathology; D012226:Rhinoscleroma / Q000188:drug therapy* / Q000473:pathology
D000166:Acridines; D000167:Acriflavine